MBRX vs NOW · $8.2M cap vs P/E 69, rev $3.99B
Moleculin Biotech Inc (MBRX) versus ServiceNow Inc (NOW) — a side-by-side from cached financials, not a winner call.
Moleculin Biotech Inc (MBRX) is a biotechnology company listed on US.
ServiceNow Inc (NOW) is a software - application company listed on US. It is led by Bill McDermott.
Latest reported MBRX revenue for 2026-06-30 was $0. Net income was -$20.5M. MBRX currently screens at market cap $8.2M.
Latest reported NOW revenue for 2026-06-30 was $3.99B. Net income was $298.0M. Revenue was up 5.8% from 2026-03-31 to 2026-06-30. NOW currently screens at market cap $119.00B and trailing P/E 68.7.
MBRX currently screens at market cap $8.2M. NOW currently screens at market cap $119.00B and trailing P/E 68.7.
Not investment advice. Open the MBRX and NOW stock pages for the full models.
Not investment advice.